Effect of Immunotherapy on Seizure Outcome in Patients with Autoimmune Encephalitis: A Prospective Observational Registry Study

PloS One
Jung-Ick ByunSang Kun Lee

Abstract

To evaluate the seizure characteristics and outcome after immunotherapy in adult patients with autoimmune encephalitis (AE) and new-onset seizure. Adult (age ≥18 years) patients with AE and new-onset seizure who underwent immunotherapy and were followed-up for at least 6 months were included. Seizure frequency was evaluated at 2-4 weeks and 6 months after the onset of the initial immunotherapy and was categorized as "seizure remission", "> 50% seizure reduction", or "no change" based on the degree of its decrease. Forty-one AE patients who presented with new-onset seizure were analysed. At 2-4 weeks after the initial immunotherapy, 51.2% of the patients were seizure free, and 24.4% had significant seizure reduction. At 6 months, seizure remission was observed in 73.2% of the patients, although four patients died during hospitalization. Rituximab was used as a second-line immunotherapy in 12 patients who continued to have seizures despite the initial immunotherapy, and additional seizure remission was achieved in 66.6% of them. In particular, those who exhibited partial response to the initial immunotherapy had a better seizure outcome after rituximab, with low adverse events. AE frequently presented as seizure, but only 18.9% o...Continue Reading

References

Jan 30, 1999·Epilepsia·D H LowensteinR L Macdonald
Aug 7, 2003·Seminars in Radiation Oncology·Andy TrottiPhilip Rubin
Mar 15, 2008·Lancet Neurology·Josep Dalmau, Myrna R Rosenfeld
May 9, 2009·Nature Reviews. Immunology·Betty DiamondBruce T Volpe
Mar 19, 2011·Annals of Neurology·Sarosh R IraniAngela Vincent
Jul 13, 2011·Neurology·Eric LancasterJosep Dalmau
Mar 27, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Luigi ZulianiAngela Vincent
Mar 28, 2012·Archives of Neurology·Amy M L QuekSean J Pittock
Apr 28, 2012·Brain : a Journal of Neurology·Christian G BienJan Bauer
Oct 12, 2012·European Neurology·Franz Josef HolzerMargitta Seeck
Jun 19, 2013·Epileptic Disorders : International Epilepsy Journal with Videotape·Nese DericiogluMehmet Akif Topcuoglu
Sep 6, 2013·Epilepsia·Rebecca Davis, Josep Dalmau
Feb 26, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Christian G Bien, Jan Bauer
Mar 19, 2014·Neuro-oncology·Josep Dalmau, Myrna R Rosenfeld
Mar 26, 2014·Journal of Neuroimmunology·Tae-Joon KimSang Kun Lee
Aug 13, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·R IorioA Evoli
Aug 30, 2014·Epilepsy & Behavior : E&B·Rani A SarkisZeina N Chemali
Apr 14, 2015·Journal of Neuroimmunology·Jun-Sang SunwooKon Chu
Jun 21, 2015·Neurology·Marianna SpatolaAndrea O Rossetti

❮ Previous
Next ❯

Citations

May 14, 2016·Expert Review of Neurotherapeutics·Divyanshu DubeySteven Vernino
Oct 13, 2017·Pharmacoepidemiology and Drug Safety·Bassam FarranPaul M McKeigue
Jan 24, 2019·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Zhihua SiKe Hu
Jun 14, 2020·Acta Neurologica Scandinavica·Guanzhong NiZiyi Chen
Mar 25, 2019·Experimental and Therapeutic Medicine·Danyan ChenBinghan Zhang
Jun 3, 2020·Acta Neurologica Scandinavica·Gaurav NepalBikram Prasad Gajurel
Feb 6, 2018·Therapeutic Advances in Neurological Disorders·Yong-Won ShinKon Chu
Jan 27, 2019·AJNR. American Journal of Neuroradiology·T StrohmM Larvie
Feb 25, 2017·Current Opinion in Neurology·Marianna Spatola, Josep Dalmau
May 13, 2020·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Brad J KollsAlok K Sahgal
May 14, 2020·Epilepsia·Robb WesselinghMastura Monif
Jun 27, 2019·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Khalil S Husari, Divyanshu Dubey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved